Uma R. Chatterjee, M.S., MHPS (@umarchatterjee) 's Twitter Profile
Uma R. Chatterjee, M.S., MHPS

@umarchatterjee

🧠Neuro PhD Stdt﹢@NIH TL1 Fellow studying OCD﹢psychedelics🍄 Cahill Lab @UW_NTP | SciComm @AChatWithUma🎙️| #DisabledInSTEM🎗️| @OCDWisconsin VP﹢@IOCDF Advocate

ID: 1497649773498748933

linkhttps://umarchatterjee.com/ calendar_today26-02-2022 19:13:09

950 Tweet

917 Takipçi

1,1K Takip Edilen

Dr. Cecilia A. Hinojosa (@ceciahinojosa) 's Twitter Profile Photo

I will accept a PhD student (Clinical Psychology or Cognition, Brain & Behavior focused) to start at Univ. of New Mexico in Fall 2025. Please visit our website to learn more: thehinojosalab.com/for-students Please feel free to reach out with any questions!

Uma R. Chatterjee, M.S., MHPS (@umarchatterjee) 's Twitter Profile Photo

I’m incredibly grateful to be attending & presenting at #EBPS2024 as a Travel Awardee! 🧠🙏🏾 So thrilled to be presenting my work on the effects of MDMA-AT for PTSD on comorbid OCD - esp. relevant given all recent MDMA developments. Can’t wait to meet & learn from everyone! 🤩🙌🏾

Leah Mayo (@mayoonthebrain) 's Twitter Profile Photo

Uma R. Chatterjee, M.S., MHPS Eur Behav Pharm Soc. Thank you for the kind words, Uma! Making science accessible and inclusive is always a priority, especially for our up-and-coming ECRs 💫 Looking forward to seeing you in Banff & hearing more about your work!

International OCD Foundation (@iocdf) 's Twitter Profile Photo

We love watching our advocates in action! Check out Uma R. Chatterjee, M.S., MHPS's latest appearance on NOCD 's "Get to Know OCD" Podcast: How Battling OCD Led This Scientist to Groundbreaking Discoveries. In this episode, Uma provides critical information on OCD and Exposure

We love watching our advocates in action! 

Check out <a href="/UmaRChatterjee/">Uma R. Chatterjee, M.S., MHPS</a>'s latest appearance on <a href="/treatmyocd/">NOCD</a> 's "Get to Know OCD" Podcast: How Battling OCD Led This Scientist to Groundbreaking Discoveries.

In this episode, Uma provides critical information on OCD and Exposure
Hugo Bayer (@hugobayer1) 's Twitter Profile Photo

The first piece of my PhD work is out in Neuropsychopharmacology! We explored the effects of infralimbic stimulation and protein synthesis inhibition during fear memory consolidation🧵 Steve Maren 🐀🧠💭😨 James Hassell Vitor Juliano et al. nature.com/articles/s4138…

Dionna Williams, PhD Lab (@dwwilliamslab) 's Twitter Profile Photo

Learning I was Autistic 1.5 years ago changed my life and led me on a journey of self acceptance and love. It’s also made me a more compassionate and effective mentor! Listen to learn more about Autism and supporting the neurodivergent folks in your life podcasters.spotify.com/pod/show/cathe…

Leah Mayo (@mayoonthebrain) 's Twitter Profile Photo

We are ~1 month out from #EBPS2024🤩 The room block has sold out, but there may be a limited # of rooms available at the venue, so book ASAP! You don't want to miss hearing from these amazing speakers - in such a stunning location - so register now: ebps2024.azuleon.org

We are ~1 month out from #EBPS2024🤩

The room block has sold out, but there may be a limited # of rooms available at the venue, so book ASAP!

You don't want to miss hearing from these amazing speakers - in such a stunning location - so register now: ebps2024.azuleon.org
Yale Psychiatry (@yalepsych) 's Twitter Profile Photo

Yale School of Medicine researchers have been awarded a $20.6 million federal grant for a five-year study of people with a wide range of mental illnesses. Project leaders are, from left, Dr. Chris Pittenger, Sarah Yip, and Dr. Godfrey Pearlson. tinyurl.com/299ru682

<a href="/YaleMed/">Yale School of Medicine</a> researchers have been awarded a $20.6 million federal grant for a five-year study of people with a wide range of mental illnesses. Project leaders are, from left, <a href="/DrChrisPitt/">Dr. Chris Pittenger</a>, <a href="/yip_lab/">Sarah Yip</a>, and Dr. Godfrey Pearlson. tinyurl.com/299ru682
Leah Mayo (@mayoonthebrain) 's Twitter Profile Photo

Are you joining for the Eur Behav Pharm Soc. workshop in Banff next month?🤔 We're covering all your favorites - psilocybin, ketamine, MDMA, cannabinoids, orexins, & more! #EBPS2024 There's still time - registration closes in 10 days (Sept 9) so sign up now: ebps2024.azuleon.org

Are you joining for the <a href="/EurBehavPharm/">Eur Behav Pharm Soc.</a> workshop in Banff next month?🤔

We're covering all your favorites - psilocybin, ketamine, MDMA, cannabinoids, orexins, &amp; more! #EBPS2024

There's still time - registration closes in 10 days (Sept 9) so sign up now: ebps2024.azuleon.org
Uma R. Chatterjee, M.S., MHPS (@umarchatterjee) 's Twitter Profile Photo

I’m so excited to attend Eur Behav Pharm Soc.’s #EBPS2024 as a travel awardee! I’ll be presenting a data blitz talk & poster on my work assessing the effects of MDMA-assisted therapy for PTSD on comorbid OCD 🧠 ⬇️ Register to attend by 9/9 - can’t wait to see everyone in Banff! 🏔️

David B. Yaden (@existwell) 's Twitter Profile Photo

It’s high time the field of psychedelic research move beyond the mystical experience construct (MEQ). While many critiques of the measure rest on misconceptions, persistent misunderstandings & psychometric limitations lead us to recommend transcending it.

It’s high time the field of psychedelic research move beyond the mystical experience construct (MEQ). 

While many critiques of the measure rest on misconceptions, persistent misunderstandings &amp; psychometric limitations lead us to recommend transcending it.
OCD Action (@ocdaction) 's Twitter Profile Photo

Calling things "OCD" when they’re not doesn’t help anyone. OCD is a serious mental health issue, and misconceptions stop people from getting the help they deserve. To learn more about OCD, visit our website today ➡️ ocdaction.org.uk

Calling things "OCD" when they’re not doesn’t help anyone.

OCD is a serious mental health issue, and misconceptions stop people from getting the help they deserve.

To learn more about OCD, visit our website today ➡️ ocdaction.org.uk
International OCD Foundation (@iocdf) 's Twitter Profile Photo

The new M. Night Shyamalan film Trap uses OCD in a way that is careless and misleading. Too often, people with OCD and related disorders feel alone and misunderstood. Irresponsible portrayals like that in Trap stigmatize and further isolate those who are struggling. As the

The new M. Night Shyamalan film Trap uses OCD in a way that is careless and misleading.

Too often, people with OCD and related disorders feel alone and misunderstood. Irresponsible portrayals like that in Trap stigmatize and further isolate those who are struggling. 

As the